Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  simvastatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-17 of 17 for your search:
Start Over
Simvastatin in Colorectal Surgery
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 90
Sponsor: Other
Protocol IDs: StatCol, NCT00994903
Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-12-019, NCT01099085
The Effect of High Dose Simvastatine on Multiple Myeloma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-004933-16, NCT00281476
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0485, CDR0000477214, P50CA088843, P30CA006973, JHOC-J0485, SKCCC-J0485, J0485, JHOC-SKCCC-J0485, JHOC-04100404, NCT00334542
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SMC IRB 2005-08-011, NCT00313859
Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: J05100, CDR0000485361, P30CA006973, JHOC-J05100, JHOC-SKCCC-J05100, J05100, NCT00354640
Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NCCCTS-06-177, NCT00452244
Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NCCCTS-06-176, NCT00452634
Simvastatin in Waldenstrom's Macroglobulinemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-175, NCT00575965
Phase II Study of Simvastatin in Primary Breast Cancer; Test of Its Potential Selectivity on Basal Subtype Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: BR04/18/08, NCT00807950
Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-07-065, NCT00944463
Phase II Study of Simvastatin and Panitumumab in Patients With K-ras Mutant-Type Advanced or Metastatic Colorectal Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information.
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other
Protocol IDs: DUT-LUMC-30012009, LUMC-RASTAT-P-30012009, EUDRACT-2009-014452-30, EU-21033, DUT-LUMC-RASTAT-P, NL-29611-058-09, NCT01110785
Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SMC IRB 2010-08-006, NCT01281761
A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 and over
Sponsor: Other
Protocol IDs: IRB no : 2013-07-088, NCT02026583
High-dose HMG-CoA Inhibitor Simvastatin Relapsed CLL
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-LEUK-06-MCC, NCT00828282
Statin Therapy Versus Placebo Prior to Prostatectomy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CLIN-013-07S, VA IRB#1735, SOL-07130-L, NCT00572468
Start Over